The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Gene Review

OMS  -  otitis media, susceptibility to

Homo sapiens

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of OMS


Psychiatry related information on OMS

  • The need for outcome monitoring systems (OMS) in substance abuse treatment is now such a pervasive position that it has achieved 'motherhood' stature [6].

High impact information on OMS


Biological context of OMS

  • In contrast to the a- or hypoplasia and regeneration of the hematopoiesis following chemotherapy, the evolution of myelosclerotic lesions showed a very uniform pattern throughout the skeleton and obviously no reversal of a manifest MS/OMS after cytotoxic treatment [12].
  • At this concentration, OMS 2017 affected fecundity of the mosquito but diflubenzuron did not [13].
  • RESULTS: Divided into different disciplines (imaging, abdominal and thoracic surgery, ENT, OMS, neurosurgery, orthopaedic surgery, radiosurgery, trauma surgery, urology), 159 robot systems are introduced [14].
  • The megakaryocyte morphology was closely related to a facultative or obligatory increase of the platelet count in these various entities of CMPD and was separable into two major categories: (1) controls, CGL and myelitis versus (2) CMGM, MF/OMS, P. vera, TH and PTH [15].

Anatomical context of OMS

  • The density distribution shows an increase of megakaryocyte number in those 5 different marrow disorders, ranging from about 13/mm2 in the normal sample up to 65 cells/mm2 in MF/OMS [16].
  • Aberrations are particularly conspicuous when pure granulocytic proliferation or neoplasia of CGL is compared with the so-called mixed cellularity of megakaryocytes and granulocytes in CMGM including MF/OMS [17].
  • Our measurements suggests 3 distinct categories of bone marrow lesions with corresponding alterations of the megakaryopoiesis: (i) myelitis and CGL; (ii) P. vera; (iii) CMGM and MF/OMS [16].
  • In most cases, MF/OMS was shown (by means of follow-up biopsies) to arise out of those entities of MPD which had included megakaryocytic hyperplasia and to which the proliferation of fibroblasts was secondary [18].

Associations of OMS with chemical compounds

  • Elevated values for urinary hydroxyproline excretion were found in 10 patients (1 AMF patient, 3 OMS patients and 6 patients with CML in the accelerated phase of the disease) [19].
  • OMS 2017 and DFB had no effect on either the amount of blood ingested or the microfilarial load [20].
  • An operational trial of Vectron (Etofenprox, OMS 3002) was conducted in East Flores Regency, Nusa Tenggara Timur Province [21].
  • 3. Organophosphate-resistant S. damnosum s.l. larvae show increased susceptibility to some organochlorine and pyrethroid insecticides, especially to permethrin (up to 11-fold) and OMS 3002 (up to 17-fold), as compared with organophosphate-susceptible populations [22].
  • Molluscicidal activity of B-2 (sodium 2,5-dichloro-4-bromophenol; called as Phebrol and registered in WHO as OMS 3012) was evaluated in a laboratory and the field trials were performed in two different localities in Yueyang city, China, for control of Oncomelania hupensis [23].

Analytical, diagnostic and therapeutic context of OMS

  • OMS programs offering MD degrees: survey of admission and educational requirements. Oral and maxillofacial surgery [24].
  • METHODS: Eleven freestanding ambulatory surgery centers (ASCs) reported process and outcome data for 3,966 outpatient surgical procedures to an outcomes monitoring system (OMS), during a demonstration period from April 1997 to April 1999 [25].


  1. p53 expression compared with other prognostic factors in OMS grade-I stage-Ta transitional cell carcinoma of the bladder. Casetta, G., Gontero, P., Russo, R., Pacchioni, D., Tizzani, A. Eur. Urol. (1997) [Pubmed]
  2. Leukemia-related morphological features in blast cells. Aus, H.M., Harms, H., Haucke, M., Beritova, J., ter Meulen, V., Gunzer, U., Baumann, I., Abmayr, W. Cytometry. (1986) [Pubmed]
  3. Potential of bone marrow biopsy in chronic myeloproliferative disorders (MPD). Bartl, R., Frisch, B., Wilmanns, W. Eur. J. Haematol. (1993) [Pubmed]
  4. Phase I trial of Perrimustine, a new cysteamine (2-chloroethyl) nitrosourea: an intrapatient escalation scheme. Kim-Triana, B., Misset, J.L., Madelmont, J.C., Godenèche, D., Musset, M., Mathé, G. Anticancer Drugs (1992) [Pubmed]
  5. Ameloblastoma in children. Ord, R.A., Blanchaert, R.H., Nikitakis, N.G., Sauk, J.J. J. Oral Maxillofac. Surg. (2002) [Pubmed]
  6. Rationales, obstacles and strategies for local outcome monitoring systems in substance abuse treatment settings. Brown, T.G., Topp, J., Ross, D. Journal of substance abuse treatment. (2003) [Pubmed]
  7. Shape-controlled synthesis of manganese oxide octahedral molecular sieve three-dimensional nanostructures. Yuan, J., Li, W.N., Gomez, S., Suib, S.L. J. Am. Chem. Soc. (2005) [Pubmed]
  8. Recent advances in immunologic reactivity in otitis media with effusion. Bernstein, J.M. J. Allergy Clin. Immunol. (1988) [Pubmed]
  9. Body composition and echocardiographic abnormalities associated to anemia and volume overload in heart failure patients. Col??n-Ram??rez, E., Castillo-Mart??nez, L., Orea-Tejeda, A., Asensio Lafuente, E., Torres Villanueva, F., Rebollar Gonz??lez, V., Narv??ez David, R., Dorantes Garc??a, J. Clinical nutrition (Edinburgh, Scotland) (2006) [Pubmed]
  10. DERM/MIS update. The Dermatology Management and Information System of the American Academy of Dermatology. Kopf, A.W., Rosenthal, L.E., Levit, F. J. Am. Acad. Dermatol. (1983) [Pubmed]
  11. Evaluating occupational health and safety programs in the public sector. Mitchell, C.S. Am. J. Ind. Med. (1998) [Pubmed]
  12. Autopsy and clinical findings in acute leukemia and chronic myeloproliferative diseases--an evaluation of 104 patients. Thiele, J., Laubert, A., Vykoupil, K.F., Georgii, A. Pathol. Res. Pract. (1985) [Pubmed]
  13. Effects of the insect growth regulators OMS 2017 and diflubenzuron on the reproductive potential of Aedes aegypti. Fournet, F., Sannier, C., Monteny, N. J. Am. Mosq. Control Assoc. (1993) [Pubmed]
  14. Today's state of the art in surgical robotics*. Pott, P.P., Scharf, H.P., Schwarz, M.L. Comput. Aided Surg. (2005) [Pubmed]
  15. Megakaryopoiesis in chronic myeloproliferative diseases. A morphometric evaluation with special emphasis on primary thrombocythemia. Thiele, J., Funke, S., Holgado, S., Choritz, H., Georgii, A. Analytical and quantitative cytology. (1984) [Pubmed]
  16. Density distribution and size of megakaryocytes in inflammatory reactions of the bone marrow (myelitis) and chronic myeloproliferative diseases. Thiele, J., Holgado, S., Choritz, H., Georgii, A. Scandinavian journal of haematology. (1983) [Pubmed]
  17. Abnormalities of megakaryocytes in myelitis and chronic myeloproliferative diseases. Thiele, J., Holgado, S., Choritz, H., Georgii, A. Virchows Arch., B, Cell Pathol. (1982) [Pubmed]
  18. Histologic criteria for classification and differential diagnosis of chronic myeloproliferative disorders. Frisch, B., Bartl, R., Burkhardt, R., Jäger, K. Haematologia (Budap) (1984) [Pubmed]
  19. Urinary hydroxyproline excretion in the myelofibrosis-osteomyelosclerosis syndrome and related diseases. Hasselbalch, H. Eur. J. Haematol. (1987) [Pubmed]
  20. Effects of two insect growth regulators on the susceptibility of Aedes aegypti (Diptera:Culicidae) to Molinema dessetae (Nematoda:Filarioidea). Fournet, F., Sannier, C., Monteny, N. J. Am. Mosq. Control Assoc. (1997) [Pubmed]
  21. A field trial with etofenprox (OMS 3002) as a residual insecticide against malaria vectors, in Tanjung Bunga district, east Flores, Indonesia. Nalim, S., Barodji, n.u.l.l., Widiarti, n.u.l.l., Widiyastuti, U. Southeast Asian J. Trop. Med. Public Health (1997) [Pubmed]
  22. Management of insecticide resistance in control of the Simulium damnosum complex by the Onchocerciasis Control Programme, West Africa: potential use of negative correlation between organophosphate resistance and pyrethroid susceptibility. Kurtak, D., Meyer, R., Ocran, M., Ouédraogo, M., Renaud, P., Sawadogo, R.O., Télé, B. Med. Vet. Entomol. (1987) [Pubmed]
  23. Laboratory and field assessment of molluscicidal activity of B-2 against Oncomelania hupensis, the vector snail of schistosomiasis in China. Wong, M.W., Xia, C.B., Chen, M.L., Zhang, C.X., Mao, P.S., Nei, G.Q., Hosaka, Y. Jpn. J. Med. Sci. Biol. (1988) [Pubmed]
  24. OMS programs offering MD degrees: survey of admission and educational requirements. Oral and maxillofacial surgery. Hallaian, K.M., Fonseca, R.J. Dentistry (American Student Dental Association) (1997) [Pubmed]
  25. Internet-based monitoring and benchmarking in ambulatory surgery centers. Bovbjerg, V.E., Olchanski, V., Zimberg, S.E., Green, J.S., Rossiter, L.F. The Joint Commission journal on quality improvement. (2000) [Pubmed]
WikiGenes - Universities